Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,547 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04428788 | Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 131 | CelgeneINDUSTRY | 1 | Dec 22, 2025 | clinicaltrials |
| NCT06055946 | Symmcora® Long-term Bidirectional Barbed Suture for Anastomosis in Patients Undergoing Robot Assisted Radical Prostatectomy(BARVANA LONG) | completed | — | 70 | Aesculap AGINDUSTRY | 1 | Dec 22, 2025 |
| clinicaltrials |
| NCT02485379 | Assessment of Prostate MRI Before Prostate Biopsies(MRI-FIRST01) | completed | N/A | 275 | Hospices Civils de LyonOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT02618200 | Creation of an Image Database for the Development of a Computer Aided Diagnostic (CAD) System in Patients With Prostate Cancer(Echo-CAD) | completed | N/A | 2 | Hospices Civils de LyonOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT02651948 | Transperineal, MRI-guided, Prostate Biopsy | completed | Phase 4 | 90 | University Hospital, Strasbourg, FranceOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT04037358 | RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers(RAVENS) | completed | Phase 2 | 64 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT00117286 | Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer | completed | Phase 2 / Phase 3 | 57 | Ferring PharmaceuticalsINDUSTRY | 2 | Dec 18, 2025 | clinicaltrials |
| NCT03009981 | A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer | completed | Phase 3 | 504 | Alliance Foundation Trials, LLC.OTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT02600156 | Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors | completed | N/A | 7 | Mayo ClinicOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT04034095 | A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan | completed | — | 979 | Janssen Pharmaceutical K.K.INDUSTRY | 1 | Dec 15, 2025 | clinicaltrials |
| NCT01577836 | Medico-economic Comparison of Robot-assisted Radical Prostatectomy Versus Radical Prostatectomy Via Laparotomy(RoboProstate) | completed | N/A | 90 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Dec 12, 2025 | clinicaltrials |
| NCT06462014 | Description of Relugolix Use in Patients With Prostate Cancer Within the VHA | completed | — | 507 | PfizerINDUSTRY | 1 | Dec 11, 2025 | clinicaltrials |
| NCT05162573 | EBRT + Lu-PSMA for N1M0 Prostate Cancer(PROQURE-1) | completed | Phase 1 | 14 | The Netherlands Cancer InstituteOTHER | 1 | Dec 10, 2025 | clinicaltrials |
| NCT05650021 | Rectal Spacer for Prostate Cancer Radiation Image Guidance | completed | N/A | 17 | Milton S. Hershey Medical CenterOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT06094322 | Evaluation of Rapid T2-weighted and DWI MR Sequences Reconstructed by Deep Learning for Prostate Imaging(DLRPRO) | completed | N/A | 34 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT07086651 | A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC) | completed | — | 1,300 | PfizerINDUSTRY | 1 | Dec 8, 2025 | clinicaltrials |
| NCT03007732 | Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT | completed | Phase 2 | 23 | David OhOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT04501913 | Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes | completed | — | 22 | City of Hope Medical CenterOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT06125145 | Geriatric Assessment and Promotores (GAP) Pilot Feasibility Study(GAP) | completed | N/A | 30 | University of California, DavisOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT01089387 | Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile Dysfunction(INSTIN) | completed | Phase 1 / Phase 2 | 18 | Institut National de la Santé Et de la Recherche Médicale, FranceOTHER_GOV | 1 | Dec 4, 2025 | clinicaltrials |
| NCT03232411 | Biobank for African American Prostate Cancer Research in Florida | completed | — | 592 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT03407963 | Feasibility of Prostatic Arterial Embolization in Low-risk Patients With Unilateral Prostate Cancer Under Active Surveillance: Monocentric Pilot Study(CAPEMBOL) | completed | N/A | 10 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT04447703 | Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study | completed | N/A | 346 | Thomas Jefferson UniversityOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT04543903 | Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer | completed | N/A | 1 | Alpha Tau Medical LTD.INDUSTRY | 1 | Dec 2, 2025 | clinicaltrials |
| NCT03284684 | Kinetics of Perioperative Circulating DNA in Cancer Surgery(Periop ctDNA) | completed | — | 30 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Dec 1, 2025 | clinicaltrials |
| NCT06128525 | Prostate Resection After Microwave Ablation (PRAMA) | completed | N/A | 1 | University of Southern CaliforniaOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT07242144 | Effect of Changes in Endotracheal Tube Cuff Pressure on Postoperative Pharyngolaryngeal Complications in Robotic Surgery | completed | — | 50 | Ege UniversityOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT01147965 | QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA | completed | Phase 1 / Phase 2 | 43 | NantCell, Inc.INDUSTRY | 1 | Nov 25, 2025 | clinicaltrials |
| NCT01961843 | Abiraterone Acetate for Castrate Resistant Prostate Cancer | completed | N/A | 40 | Massachusetts General HospitalOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT00853710 | Test Semiquantitative Prostate Specific Antigen (PSA) | completed | N/A | 94 | Institut CurieOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT02050542 | Study of Current Practice Which Compare the Rate of Prostate Cancer by Using 2 Kind of Transrectal Biopsies: 3 by IRM-echography Image Fusion and 12 Systematized Guided Echographies.(MURIELLE) | completed | N/A | 108 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT04702633 | Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer(PROSTA-PAP) | completed | — | 127 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT05472532 | Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture)(INOVOLINE) | completed | N/A | 101 | Hospices Civils de LyonOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT05220501 | Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI(OPTIMUM) | completed | N/A | 804 | Sunnybrook Health Sciences CentreOTHER | 8 | Nov 10, 2025 | clinicaltrials |
| NCT03734653 | Testosterone Therapy in Castration Resistant Prostate Cancer | completed | Early Phase 1 | 30 | University of Colorado, DenverOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| NCT05978232 | NAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer Patients | completed | N/A | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT03860961 | Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy | completed | N/A | 550 | NRG OncologyOTHER | 1 | Nov 3, 2025 | clinicaltrials |
| NCT05311527 | UroLift System With SAbR for Prostate Cancer and BPH | completed | N/A | 15 | University of Texas Southwestern Medical CenterOTHER | 1 | Oct 31, 2025 | clinicaltrials |
| NCT06250751 | Behavioral Exercise TRaining for Men Undergoing Androgen Depr Therapy for Prostate Ca(BETR-PC) | completed | N/A | 27 | Virginia Commonwealth UniversityOTHER | 1 | Oct 31, 2025 | clinicaltrials |
| NCT03480646 | ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer | completed | Phase 1 / Phase 2 | 175 | Constellation PharmaceuticalsINDUSTRY | 1 | Oct 29, 2025 | clinicaltrials |
| NCT02203695 | Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy | completed | Phase 2 | 86 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 28, 2025 | clinicaltrials |
| NCT02294461 | An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants | completed | Phase 3 | 395 | Astellas Pharma IncINDUSTRY | 4 | Oct 24, 2025 | clinicaltrials |
| NCT07220499 | Whole Food Plant-based Diet to Improve Outcomes in Prostate Cancer | completed | N/A | 11 | Pacific Cancer CareOTHER | 1 | Oct 24, 2025 | clinicaltrials |
| NCT04838613 | Study of Diagnostic Performance of [18F]CTT1057 in BCR(GuidePath) | completed | Phase 3 | 190 | Novartis PharmaceuticalsINDUSTRY | 4 | Oct 20, 2025 | clinicaltrials |
| NCT02141438 | Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer(REASSURE) | completed | — | 1,472 | BayerINDUSTRY | 20 | Oct 16, 2025 | clinicaltrials |
| NCT03507608 | Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression | completed | Early Phase 1 | 25 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 16, 2025 | clinicaltrials |
| NCT03580499 | Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy | completed | N/A | 43 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT03939689 | I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).(ARROW) | completed | Phase 2 | 120 | Progenics Pharmaceuticals, Inc.INDUSTRY | 2 | Oct 14, 2025 | clinicaltrials |
| NCT03253744 | Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy | completed | Phase 1 | 17 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2025 | clinicaltrials |
| NCT04838626 | Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection(GuideView) | completed | Phase 2 / Phase 3 | 195 | Novartis PharmaceuticalsINDUSTRY | 5 | Oct 7, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Dec 22, 2025source: clinicaltrials